Journal article

Interleukin-6 gene promoter-572 C allele may play a role in rate of disease progression in multiple sclerosis

J Yan, J Liu, CY Lin, RJ Scott, J Lechner-Scott, DR Booth, GJ Stewart, S Broadley, D Mason, L Griffiths, P Moscato, M Slee, B Taylor, J Wiley, J Field, H Butzkueven, TJ Kilpatrick, PA Csurhes, MP Pender, PA McCombe Show all

International Journal of Molecular Sciences | MDPI AG | Published : 2012

Abstract

Multiple sclerosis (MS) is an inflammatory demyelinating disease affecting the central nervous system. Although the exact pathogenesis of MS is unknown, it is generally considered to be an autoimmune disease, with numerous genetic and environmental factors determining disease susceptibility and severity. One important mediator of immune responses and inflammation is interleukin-6 (IL-6). Previously, elevated levels of IL-6 in mononuclear cells in blood and in brain tissue from MS patients have been reported. Various polymorphisms in the promoter region of the IL6 gene have also been linked with IL-6 protein levels. In MS, several small studies have investigated whether two IL6 promoter polym..

View full abstract

University of Melbourne Researchers